8 Coupons
-
Special Offer
-
30% off
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”
. by continuing to use this site you consent to the use of cookies on your device as described in our
.
.